DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Delucemine
Delucemine
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
(12) United States Patent (10) Patent N0.: US 7,964,607 B2 Verhoest Et A1
Ep 2932971 A1
Studies on the Role of HDAC5, SIRT2 and VGLUT1 As Pharmacological Targets Involved in Antidepressant Action
WO 2015/069669 Al 14 May 2015 (14.05.2015) P O P C T
WO 2010/000073 Al
Customs Tariff - Schedule
Ep 2288345 B1
Pharmaceutical Appendix to the Tariff Schedule 2
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2011) (Rev
(12) United States Patent (10) Patent No.: US 8,916,564 B2 Pettersson Et Al
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
From PCP to MXE: a Comprehensive Review of the Non-Medical Use of Dissociative Drugs Hamilton Morrisa and Jason Wallachb*
Customs Tariff - Schedule
(12) United States Patent (10) Patent No.: US 9,067,934 B2 Pettersson Et Al
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
( 12 ) Patent Application Publication ( 10 ) Pub . No .: US 2020/0215078 A1
Top View
(12) Patent Application Publication (10) Pub. No.: US 2015/0209438A1 Ichinose Et Al
WO 2014/018563 A2 30 January 2014 (30.01.2014)
WO 2017/065602 Al 20 April 2017 (20.04.2017) P O P C T
Neurogenesis Via Modulation of the Muscarinic Receptors
Convergent Functional Genomic Studies of Omega-3 Fatty Acids in Stress Reactivity, Bipolar Disorder and Alcoholism
WHO Drug Information Vol 19, No
(12) Patent Application Publication (10) Pub. No.: US 2013/0045979 A1 Sanfilippo (43) Pub
Q:\Users\Brendac\Pharmaceutical Zeroforzero Initiative FINAL Edited
Phase 1B Pharmaco-MRS Pilot Study of Clavulanic Acid After Repeated Administration
L:\0900\0900PHARMAPPX .Wpd
1 Depressive Disorders
(12) United States Patent (10) Patent No.: US 9.242,009 B2 Ichinose Et Al
Tepzz 88¥45 B9t